Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q3 EPS by 8c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q3 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD
• Varonis Said To Weigh Sale After Takeover Interest - Bloomberg